TacticScaleWhat Sotera Health Does & How It Makes Money (SHC)
Updated October 2026 · reflects Sotera Health's latest reported financials
Healthcare sterilization, Cobalt-60 supply, and lab testing services provider. It earns fees from medical device, pharmaceutical, and food companies that outsource sterilization and lab testing to it.
How Sotera Health makes money
It earns fees from medical device, pharmaceutical, and food companies that outsource sterilization and lab testing to it. It also sells Cobalt-60 and gamma irradiation systems.
What Sotera Health does
Sotera Health Company, headquartered in Broadview Heights, Ohio, provides sterilization, lab testing, and advisory services to the healthcare industry across the United States, Canada, Europe, and other international markets. It has three segments. Sterigenics runs outsourced terminal sterilization and irradiation using gamma irradiation, ethylene oxide, and electron beam technologies. It serves medical device, pharmaceutical, food safety, and advanced applications customers. Nordion supplies Cobalt-60, the radioactive source used in gamma sterilization and irradiation and in cancer treatment, and also provides gamma irradiation systems. Nelson Labs offers outsourced microbiological and analytical chemistry testing and advisory services for medical device and pharmaceutical companies. The company was incorporated in 2015 as Sotera Health Topco, Inc. and took its current name in October 2020.
Products & services
- Sterigenics sterilization services (gamma, ethylene oxide, electron beam)
- Nordion Cobalt-60 supply
- Nordion gamma irradiation systems
- Nelson Labs microbiological and analytical chemistry testing
- Nelson Labs advisory services
What is Sotera Health worth?
On an owner-earnings DCF, Sotera Health's most-likely value is about $10 versus a recent price near $18 (45% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$5) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
⚠ High leverage — net debt is 14.8× annual cash flow. Net debt is subtracted from this fair value, but refinancing at higher rates, principal timing, and share dilution aren’t modeled — the equity can be worth far less if cash flow weakens.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
STERIS (STE) · Solventum (SOLV) · Seres Therapeutics (MCRB) · Shinva Medical Instrument (600587.SS) · Sintx Technologies (SINT)